Autotransfusion Devices Market Size (2022-2030) Share,

Pune, Oct. 07, 2022 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global autotransfusion devices market is expected to clock US$ 386.06 by 2030 and to grow at a CAGR of 4.90% during the forecast period. The global autotransfusion devices market is primarily driven by the increasing geriatric population, growing prevalence of chronic diseases, and the consequent increase in the uptake of surgical procedures. Additionally, there are other market drivers: a shortage of blood donors, increasing cases of trauma-related accidents, and rising number of organ transplant procedures. This exclusive information is published by Growth Plus Reports in its report titled “Autotransfusion Devices Market – Global Outlook & Forecast 2022-2030”

Get a Sample Copy of the Research Report: https://growthplusreports.com/inquiry/request-sample/autotransfusion-devices-market/7856

The cell salvage technique is used in autotransfusion devices. Blood from the surgical site is collected, filtered, and processed as autologous blood for pretransfusion to the patient. The blood is collected in containers with a small amount of anticoagulant and heparin by autotransfusion devices. Autotransfusion devices retain red blood cells, while plasma, platelets, and other components are discarded with the washing solution.

Growth Drivers

Shortage of blood donors and increasing blood crisis are contributing to the global autotransfusion devices market growth. In the last three years, blood donation activity rates have been restrained because of the COVID-19 pandemic and the associated safety issue. The COVID-19 pandemic has been one of the significant factors for the shortage of blood and blood products as the restriction was imposed on travel, social gathering, and safety protocols for blood donation. This intensified the demand for autologous blood transfusion during critical surgical procedures, thus driving the global autotransfusion devices…